Advancing Clinical Response Against Glioblastoma: Evaluating SHP1705 CRY2 Activator Efficacy in Preclinical Models and Safety in Phase I Trials. - Chan P; Nagai Y; Wu Q; Hovsepyan A; Mkhitaryan S; Wang J; Karapetyan G; Kamenecka T; Solt LA; Cope J; Moats RA; Hirota T; et al. (BioRxiv : the preprint server for biology, 2024)